Global Biosimilars Market Research Report 2021

Global Biosimilars Market Research Report 2021

Table of Contents
1 Biosimilars Market Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Biosimilars Segment by Application
1.3.1 Biosimilars Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Global Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Biosimilars Revenue 2016-2027
1.4.2 Global Biosimilars Sales 2016-2027
1.4.3 Biosimilars Market Size by Region: 2016 Versus 2021 Versus 2027
2 Biosimilars Market Competition by Manufacturers
2.1 Global Biosimilars Sales Market Share by Manufacturers (2016-2021)
2.2 Global Biosimilars Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biosimilars Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biosimilars Manufacturing Sites, Area Served, Product Type
2.5 Biosimilars Market Competitive Situation and Trends
2.5.1 Biosimilars Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biosimilars Players Market Share by Revenue
2.5.3 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biosimilars Retrospective Market Scenario by Region
3.1 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Biosimilars Market Facts & Figures by Country
3.3.1 North America Biosimilars Sales by Country
3.3.2 North America Biosimilars Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilars Market Facts & Figures by Country
3.4.1 Europe Biosimilars Sales by Country
3.4.2 Europe Biosimilars Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilars Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilars Sales by Region
3.5.2 Asia Pacific Biosimilars Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biosimilars Market Facts & Figures by Country
3.6.1 Latin America Biosimilars Sales by Country
3.6.2 Latin America Biosimilars Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biosimilars Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilars Sales by Country
3.7.2 Middle East and Africa Biosimilars Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biosimilars Historic Market Analysis by Type
4.1 Global Biosimilars Sales Market Share by Type (2016-2021)
4.2 Global Biosimilars Revenue Market Share by Type (2016-2021)
4.3 Global Biosimilars Price by Type (2016-2021)
5 Global Biosimilars Historic Market Analysis by Application
5.1 Global Biosimilars Sales Market Share by Application (2016-2021)
5.2 Global Biosimilars Revenue Market Share by Application (2016-2021)
5.3 Global Biosimilars Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biocon Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Biogen
6.4.1 Biogen Corporation Information
6.4.2 Biogen Description and Business Overview
6.4.3 Biogen Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biogen Product Portfolio
6.4.5 Biogen Recent Developments/Updates
6.5 Fresenius Kabi AG
6.5.1 Fresenius Kabi AG Corporation Information
6.5.2 Fresenius Kabi AG Description and Business Overview
6.5.3 Fresenius Kabi AG Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Fresenius Kabi AG Product Portfolio
6.5.5 Fresenius Kabi AG Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Boehringer Ingelheim Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Merck KgaA
6.6.1 Merck KgaA Corporation Information
6.6.2 Merck KgaA Description and Business Overview
6.6.3 Merck KgaA Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck KgaA Product Portfolio
6.7.5 Merck KgaA Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Mylan Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Eli Lilly Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Corporation Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Teva Pharmaceutical Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Corporation Information
6.11.2 Dr. Reddy's Laboratories Biosimilars Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Dr. Reddy's Laboratories Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Amgen
6.12.1 Amgen Corporation Information
6.12.2 Amgen Biosimilars Description and Business Overview
6.12.3 Amgen Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Amgen Product Portfolio
6.12.5 Amgen Recent Developments/Updates
6.13 Celltrion
6.13.1 Celltrion Corporation Information
6.13.2 Celltrion Biosimilars Description and Business Overview
6.13.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Celltrion Product Portfolio
6.13.5 Celltrion Recent Developments/Updates
6.14 Samsung Biologics
6.14.1 Samsung Biologics Corporation Information
6.14.2 Samsung Biologics Biosimilars Description and Business Overview
6.14.3 Samsung Biologics Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Samsung Biologics Product Portfolio
6.14.5 Samsung Biologics Recent Developments/Updates
6.15 Roche
6.15.1 Roche Corporation Information
6.15.2 Roche Biosimilars Description and Business Overview
6.15.3 Roche Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Roche Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 Probiomed
6.16.1 Probiomed Corporation Information
6.16.2 Probiomed Biosimilars Description and Business Overview
6.16.3 Probiomed Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Probiomed Product Portfolio
6.16.5 Probiomed Recent Developments/Updates
6.17 Apotex
6.17.1 Apotex Corporation Information
6.17.2 Apotex Biosimilars Description and Business Overview
6.17.3 Apotex Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Apotex Product Portfolio
6.17.5 Apotex Recent Developments/Updates
6.18 Chong Kun Dang
6.18.1 Chong Kun Dang Corporation Information
6.18.2 Chong Kun Dang Biosimilars Description and Business Overview
6.18.3 Chong Kun Dang Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Chong Kun Dang Product Portfolio
6.18.5 Chong Kun Dang Recent Developments/Updates
6.19 JCR Pharmaceuticals
6.19.1 JCR Pharmaceuticals Corporation Information
6.19.2 JCR Pharmaceuticals Biosimilars Description and Business Overview
6.19.3 JCR Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.19.4 JCR Pharmaceuticals Product Portfolio
6.19.5 JCR Pharmaceuticals Recent Developments/Updates
6.20 Gan & Lee Pharmaceuticals
6.20.1 Gan & Lee Pharmaceuticals Corporation Information
6.20.2 Gan & Lee Pharmaceuticals Biosimilars Description and Business Overview
6.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Gan & Lee Pharmaceuticals Product Portfolio
6.20.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.21 Gedeon Richter
6.21.1 Gedeon Richter Corporation Information
6.21.2 Gedeon Richter Biosimilars Description and Business Overview
6.21.3 Gedeon Richter Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Gedeon Richter Product Portfolio
6.21.5 Gedeon Richter Recent Developments/Updates
6.22 Biocad
6.22.1 Biocad Corporation Information
6.22.2 Biocad Biosimilars Description and Business Overview
6.22.3 Biocad Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Biocad Product Portfolio
6.22.5 Biocad Recent Developments/Updates
6.23 Coherus Bioscience
6.23.1 Coherus Bioscience Corporation Information
6.23.2 Coherus Bioscience Biosimilars Description and Business Overview
6.23.3 Coherus Bioscience Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Coherus Bioscience Product Portfolio
6.23.5 Coherus Bioscience Recent Developments/Updates
6.24 Stada Arzneimittel AG
6.24.1 Stada Arzneimittel AG Corporation Information
6.24.2 Stada Arzneimittel AG Biosimilars Description and Business Overview
6.24.3 Stada Arzneimittel AG Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Stada Arzneimittel AG Product Portfolio
6.24.5 Stada Arzneimittel AG Recent Developments/Updates
7 Biosimilars Manufacturing Cost Analysis
7.1 Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilars
7.4 Biosimilars Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilars Distributors List
8.3 Biosimilars Customers
9 Biosimilars Market Dynamics
9.1 Biosimilars Industry Trends
9.2 Biosimilars Growth Drivers
9.3 Biosimilars Market Challenges
9.4 Biosimilars Market Restraints
10 Global Market Forecast
10.1 Biosimilars Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilars by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Biosimilars by Type (2022-2027)
10.2 Biosimilars Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilars by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Biosimilars by Application (2022-2027)
10.3 Biosimilars Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilars by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Biosimilars by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Biosimilars Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Biosimilars Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Biosimilars Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Biosimilars Covered in This Study
Table 5. Global Biosimilars Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Biosimilars Sales Share by Manufacturers (2016-2021)
Table 7. Global Biosimilars Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Biosimilars Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Biosimilars Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Biosimilars Manufacturing Sites and Area Served
Table 11. Manufacturers Biosimilars Product Type
Table 12. Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biosimilars Sales by Region (2016-2021) & (K MT)
Table 16. Global Biosimilars Sales Market Share by Region (2016-2021)
Table 17. Global Biosimilars Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Biosimilars Sales by Country (2016-2021) & (K MT)
Table 19. North America Biosimilars Sales Market Share by Country (2016-2021)
Table 20. North America Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Biosimilars Revenue Market Share by Country (2016-2021)
Table 22. Europe Biosimilars Sales by Country (2016-2021) & (K MT)
Table 23. Europe Biosimilars Sales Market Share by Country (2016-2021)
Table 24. Europe Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Biosimilars Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Biosimilars Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Biosimilars Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Biosimilars Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Biosimilars Revenue Market Share by Region (2016-2021)
Table 30. Latin America Biosimilars Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Biosimilars Sales Market Share by Country (2016-2021)
Table 32. Latin America Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Biosimilars Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Biosimilars Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Biosimilars Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Biosimilars Revenue Market Share by Country (2016-2021)
Table 38. Global Biosimilars Sales (K MT) by Type (2016-2021)
Table 39. Global Biosimilars Sales Market Share by Type (2016-2021)
Table 40. Global Biosimilars Revenue (Million US$) by Type (2016-2021)
Table 41. Global Biosimilars Revenue Share by Type (2016-2021)
Table 42. Global Biosimilars Price (USD/MT) by Type (2016-2021)
Table 43. Global Biosimilars Sales (K MT) by Application (2016-2021)
Table 44. Global Biosimilars Sales Market Share by Application (2016-2021)
Table 45. Global Biosimilars Revenue (Million US$) by Application (2016-2021)
Table 46. Global Biosimilars Revenue Share by Application (2016-2021)
Table 47. Global Biosimilars Price (USD/MT) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Pfizer Biosimilars Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Novartis Biosimilars Product
Table 57. Novartis Recent Developments/Updates
Table 58. Biocon Corporation Information
Table 59. Biocon Description and Business Overview
Table 60. Biocon Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Biocon Biosimilars Product
Table 62. Biocon Recent Developments/Updates
Table 63. Biogen Corporation Information
Table 64. Biogen Description and Business Overview
Table 65. Biogen Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Biogen Biosimilars Product
Table 67. Biogen Recent Developments/Updates
Table 68. Fresenius Kabi AG Corporation Information
Table 69. Fresenius Kabi AG Description and Business Overview
Table 70. Fresenius Kabi AG Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Fresenius Kabi AG Biosimilars Product
Table 72. Fresenius Kabi AG Recent Developments/Updates
Table 73. Boehringer Ingelheim Corporation Information
Table 74. Boehringer Ingelheim Description and Business Overview
Table 75. Boehringer Ingelheim Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Boehringer Ingelheim Biosimilars Product
Table 77. Boehringer Ingelheim Recent Developments/Updates
Table 78. Merck KgaA Corporation Information
Table 79. Merck KgaA Description and Business Overview
Table 80. Merck KgaA Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Merck KgaA Biosimilars Product
Table 82. Merck KgaA Recent Developments/Updates
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Mylan Biosimilars Product
Table 87. Mylan Recent Developments/Updates
Table 88. Eli Lilly Corporation Information
Table 89. Eli Lilly Description and Business Overview
Table 90. Eli Lilly Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Eli Lilly Biosimilars Product
Table 92. Eli Lilly Recent Developments/Updates
Table 93. Teva Pharmaceutical Corporation Information
Table 94. Teva Pharmaceutical Description and Business Overview
Table 95. Teva Pharmaceutical Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Teva Pharmaceutical Biosimilars Product
Table 97. Teva Pharmaceutical Recent Developments/Updates
Table 98. Dr. Reddy's Laboratories Corporation Information
Table 99. Dr. Reddy's Laboratories Description and Business Overview
Table 100. Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Dr. Reddy's Laboratories Biosimilars Product
Table 102. Dr. Reddy's Laboratories Recent Developments/Updates
Table 103. Amgen Corporation Information
Table 104. Amgen Description and Business Overview
Table 105. Amgen Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Amgen Biosimilars Product
Table 107. Amgen Recent Developments/Updates
Table 108. Celltrion Corporation Information
Table 109. Celltrion Description and Business Overview
Table 110. Celltrion Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Celltrion Biosimilars Product
Table 112. Celltrion Recent Developments/Updates
Table 113. Samsung Biologics Corporation Information
Table 114. Samsung Biologics Description and Business Overview
Table 115. Samsung Biologics Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Samsung Biologics Biosimilars Product
Table 117. Samsung Biologics Recent Developments/Updates
Table 118. Roche Corporation Information
Table 119. Roche Description and Business Overview
Table 120. Roche Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Roche Biosimilars Product
Table 122. Roche Recent Developments/Updates
Table 123. Probiomed Corporation Information
Table 124. Probiomed Description and Business Overview
Table 125. Probiomed Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Probiomed Biosimilars Product
Table 127. Probiomed Recent Developments/Updates
Table 128. Apotex Corporation Information
Table 129. Apotex Description and Business Overview
Table 130. Apotex Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 131. Apotex Biosimilars Product
Table 132. Apotex Recent Developments/Updates
Table 133. Chong Kun Dang Corporation Information
Table 134. Chong Kun Dang Description and Business Overview
Table 135. Chong Kun Dang Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 136. Chong Kun Dang Biosimilars Product
Table 137. Chong Kun Dang Recent Developments/Updates
Table 138. JCR Pharmaceuticals Corporation Information
Table 139. JCR Pharmaceuticals Description and Business Overview
Table 140. JCR Pharmaceuticals Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 141. JCR Pharmaceuticals Biosimilars Product
Table 142. JCR Pharmaceuticals Recent Developments/Updates
Table 143. Gan & Lee Pharmaceuticals Corporation Information
Table 144. Gan & Lee Pharmaceuticals Description and Business Overview
Table 145. Gan & Lee Pharmaceuticals Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 146. Gan & Lee Pharmaceuticals Biosimilars Product
Table 147. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 148. Gedeon Richter Corporation Information
Table 149. Gedeon Richter Description and Business Overview
Table 150. Gedeon Richter Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 151. Gedeon Richter Biosimilars Product
Table 152. Gedeon Richter Recent Developments/Updates
Table 153. Biocad Corporation Information
Table 154. Biocad Description and Business Overview
Table 155. Biocad Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 156. Biocad Biosimilars Product
Table 157. Biocad Recent Developments/Updates
Table 158. Coherus Bioscience Corporation Information
Table 159. Coherus Bioscience Description and Business Overview
Table 160. Coherus Bioscience Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 161. Coherus Bioscience Biosimilars Product
Table 162. Coherus Bioscience Recent Developments/Updates
Table 163. Stada Arzneimittel AG Corporation Information
Table 164. Stada Arzneimittel AG Description and Business Overview
Table 165. Stada Arzneimittel AG Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 166. Stada Arzneimittel AG Biosimilars Product
Table 167. Stada Arzneimittel AG Recent Developments/Updates
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Biosimilars Distributors List
Table 171. Biosimilars Customers List
Table 172. Biosimilars Market Trends
Table 173. Biosimilars Growth Drivers
Table 174. Biosimilars Market Restraints
Table 175. Global Biosimilars Sales Forecast by Type (2022-2027) & (K MT)
Table 176. Global Biosimilars Sales Market Share Forecast by Type (2022-2027)
Table 177. Global Biosimilars Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 178. Global Biosimilars Revenue Market Share Forecast by Type (2022-2027)
Table 179. Global Biosimilars Sales Forecast by Application (2022-2027) & (K MT)
Table 180. Global Biosimilars Sales Market Share Forecast by Application (2022-2027)
Table 181. Global Biosimilars Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 182. Global Biosimilars Revenue Market Share Forecast by Application (2022-2027)
Table 183. Global Biosimilars Sales Forecast by Region (2022-2027) & (K MT)
Table 184. Global Biosimilars Sales Market Share Forecast by Region (2022-2027)
Table 185. Global Biosimilars Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 186. Global Biosimilars Revenue Market Share Forecast by Region (2022-2027)
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biosimilars
Figure 2. Global Biosimilars Market Share by Type in 2020 & 2027
Figure 3. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure 4. Recombinant Glycosylated Proteins Product Picture
Figure 5. Global Biosimilars Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Blood Disorders
Figure 8. Growth Hormonal Deficiency
Figure 9. Chronic and Autoimmune Disorders
Figure 10. Others
Figure 11. Global Biosimilars Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biosimilars Market Size 2016-2027 (US$ Million)
Figure 13. Global Biosimilars Sales 2016-2027 (K MT)
Figure 14. Global Biosimilars Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Biosimilars Sales Share by Manufacturers in 2020
Figure 16. Global Biosimilars Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Biosimilars Players: Market Share by Revenue in 2020
Figure 18. Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Biosimilars Sales Market Share by Region (2016-2021)
Figure 20. Global Biosimilars Sales Market Share by Region in 2020
Figure 21. Global Biosimilars Revenue Market Share by Region (2016-2021)
Figure 22. Global Biosimilars Revenue Market Share by Region in 2020
Figure 23. U.S. Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Biosimilars by Type (2016-2021)
Figure 48. Sales Market Share of Biosimilars by Application (2016-2021)
Figure 49. Sales Market Share of Biosimilars by Application in 2020
Figure 50. Revenue Share of Biosimilars by Application (2016-2021)
Figure 51. Revenue Share of Biosimilars by Application in 2020
Figure 52. Manufacturing Cost Structure of Biosimilars
Figure 53. Manufacturing Process Analysis of Biosimilars
Figure 54. Biosimilars Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs